Dr Lal Pathlabs net profit slips 31.2 per cent YoY in Q4FY20
Dr Lal Pathlabs posted its March quarter results during the market’s afternoon session. Its consolidated revenue for the quarter Q4FY20 came in at Rs 301.7 crore as against Rs 301.1 crore in the corresponding quarter last year.
EBITDA for the quarter fell by 13.4 per cent YoY to Rs 57.3 crore as against Rs 66.2 crore in the corresponding quarter last year, with a corresponding margin contraction of 299 bps. EBITDA margin for the quarter stood at 19 per cent.
PAT for the quarter came in at Rs 32.6 crore as against Rs 47.4 crore in the corresponding quarter last year, with YoY decline of 31.2 per cent.
Looking at the full year numbers i.e. for FY20, the revenue jumped by 11 per cent YoY to Rs 1,330.4 crore while, EBITDA grew by 17 per cent YoY to Rs 343.6 crore. Further, the company reported net profit of Rs 227.6 crore, up by 14 per cent YoY.
In Q4FY20, patient volumes increased by 2.1 per cent led by higher growth in the rest of India market, further supported by stable momentum in the other regions. The performance for the second fortnight of March 2020 has been adversely impacted by the nationwide lockdown due to COVID-19 outbreak.
On Monday, the stock of Dr Lal Pathlabs opened at Rs 1,605.95. During the day, it made an intraday high and a low of Rs 1,611 and Rs 1,564 respectively. Later, it got closed flat at Rs 1,583.35.